Related Experiment Video

Updated: Aug 8, 2026

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung
09:26

Antibiotic Efficacy Testing in an Ex vivo Model of Pseudomonas aeruginosa and Staphylococcus aureus Biofilms in the Cystic Fibrosis Lung

Published on: January 22, 2021

[Antibiotics in otitis media with effusion]

J J Grote1

  • 1Academisch Ziekenhuis, afd. Keel-Neus-Oorheelkunde, Leiden.

Nederlands Tijdschrift Voor Geneeskunde
|January 11, 1997
PubMed

Insights

Otitis media with effusion often resolves on its own. Antibiotics offer only temporary relief and are not recommended for treating this condition, preventing long-term hearing loss.

Area of Science:

  • Otolaryngology
  • Pediatric Medicine
  • Audiology

Background:

  • Otitis media with effusion (OME) is a common condition, particularly in children.
  • While often self-limiting, persistent OME can lead to significant hearing impairment.
  • Preventing long-term hearing deficits is a primary clinical concern.

Purpose of the Study:

  • To evaluate the efficacy of antibiotic treatment for otitis media with effusion.
  • To determine the long-term impact of antibiotics on OME resolution and hearing outcomes.
  • To provide evidence-based recommendations for OME management.

Main Methods:

  • Systematic review of existing literature on OME treatment.
  • Analysis of studies comparing antibiotic therapy versus placebo or no treatment.
  • Assessment of hearing outcomes and duration of effusion in treated and untreated groups.

Main Results:

  • Antibiotic treatment demonstrates minimal to no significant long-term benefit for OME.
  • Observed effects of antibiotics are transient, with no sustained improvement in hearing or effusion resolution.
  • The available evidence does not support the routine use of antibiotics for OME.

Conclusions:

  • Antibiotic therapy is not indicated for the management of otitis media with effusion.
  • Focus should remain on monitoring for spontaneous resolution and addressing hearing impairment when necessary.
  • Alternative or conservative management strategies should be prioritized over antibiotic use for OME.

More Related Videos

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials06:18

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials

Published on: March 3, 2023

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases03:22

Microbiological Rapid On-Site Evaluation for Pulmonary Infectious Diseases

Published on: March 1, 2024

Related Concept Videos

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Tonsillitis II: Management01:26

Tonsillitis II: Management

This lesson will focus on the different treatment options for managing tonsillitis, which typically depend on the cause and severity.
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Inhibitors of Bacterial Protein Synthesis01:25

Inhibitors of Bacterial Protein Synthesis

Aminoglycosides constitute a highly potent class of bactericidal antibiotics that exert their antimicrobial effects by targeting the bacterial ribosome, specifically disrupting protein synthesis. These polycationic molecules consist of amino-modified sugars linked via glycosidic bonds to an aminocyclitol core such as 2-deoxystreptamine or streptamine. Their strong positive charges facilitate tight binding to the negatively charged phosphate backbone of ribosomal RNA (rRNA), primarily at the 16S...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...